5-year FFP contract for research and development services, BAA FY26C1AP28: mechanistic evaluation of oral peptide absorption using organoid-based nams to support bioequivalence assessment.
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00089
- Awardee
-
University Of Florida UEI NNFQH1JAPEP3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $645,503
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 39% obligated
-
- $645,503.00 Current, with exercised options
- $1,667,347.00 Potential, with all options
- Completion date 1% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Orlando, FL 32827, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $1.667 million definitive contract to the University of Florida Division of Sponsored Research for five-year research and development services on September 30, 2026, with completion by September 29, 2031.
The contract supports mechanistic evaluation of oral peptide absorption using organoid-based new approach methodologies to support bioequivalence assessment, issued under FDA Broad Agency Announcement FY26C1AP28 for advanced regulatory science research. The solicitation, posted November 21, 2025, with due date February 24, 2026, sought basic and applied research to modernize FDA-regulated product development, strengthen post-market surveillance, and advance public health preparedness. Place of performance is Orlando, Florida. The contract carries firm fixed price terms with no set-aside.
Quick answers
Who was awarded contract 75F40126C00089?
75F40126C00089 was awarded to University Of Florida by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00089 worth?
The government has obligated $645,503 on 75F40126C00089. Its potential value, with all options, is $1,667,347.
Was contract 75F40126C00089 competed?
The extent of competition for 75F40126C00089 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award